Rapid Micro Biosystems - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Lean management has become standard for manufacturers worldwide, and companies in almost every industry are stripping waste with new technologies and more efficient production processes. While pharmaceutical manufacturers have followed suit in the production of their products, they’ve been slow to embrace lean initiatives in quality control (QC) – until now.


Over the last decade, forward-thinking drug companies have adopted a variety of rapid microbiological method (RMM) technologies, complementing – and in some cases, replacing – the century-old manual method of incubating and counting colonies for microbial testing.
Compared to traditional and alternative techniques, the Growth Direct(TM) System's benefits include:
·         Automation of error prone tasks
·         Non-destructive results
·         A simple validation process
·         Network integration
·         Rapid results
Through the creation of leaner, more efficient QC labs, these benefits have allowed several major pharmaceutical companies to increase their efficiency. Download your free copy to hear their stories!

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
FindPharma Custom Search

Click here